Introduction
The Global Anatomic Pathology Market is estimated to be USD 31.98 Bn in 2022 and is expected to reach USD 45.7 Bn by 2027, growing at a CAGR of 7.4%.
Market Dynamics
Market dynamics are forces that impact the prices and behaviors of the Global Anatomic Pathology Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macroeconomic and microeconomic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals. As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.
Market Segmentations
The Global Anatomic Pathology Market is segmented based on Services, Product, Application, End User, and Geography.
ByServices, the market is classified into Cytopathology and Histopathology.
By Product, the market is classified into Consumables and Instruments.
ByApplication, the market is classified into Disease Diagnostics and Medical Research.
ByEnd User, the market is classified into Clinical Laboratories and Hospital Laboratories.
ByGeography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.
Company Profiles
The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Agilent Technologies, Inc., Associated Regional and University Pathologists, Inc., Becton, Dickinson, and Co., Bio SB Inc., BioGenex Laboratories, Cardinal Health, Inc., etc.
Countries Studied
America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)
IGR Competitive Quadrant
The report includes IGR Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Ansoff Analysis
The report presents a detailed Ansoff matrix analysis for the Global Anatomic Pathology Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach. Infogence Global Research analyses the Global Anatomic Pathology Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position. Based on the SWOT analysis conducted on the industry and industry players, Infogence Global Research has devised suitable strategies for market growth.
Why buy this report?
The report offers a comprehensive evaluation of the Global Anatomic Pathology Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
The report also contains the competitive analysis using IGR Positioning Quadrants, Infogence's Proprietary competitive positioning tool.
Report Highlights:
A complete analysis of the market, including parent industry
Important market dynamics and trends
Market segmentation
Historical, current, and projected size of the market based on value and volume
Market shares and strategies of key players
Recommendations to companies for strengthening their foothold in the market
'
1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 IGR Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Rising Reliance on Biomarkers-based Pathology Tests and Procedures
4.1.2 Increasing Prevalence of Cancer and other Chronic Diseases
4.1.3 Growing use of Advanced Pathology Equipment such as Gross Imaging, Staining Systems, and Digital Microscopes
4.2 Restraints
4.2.1 Increased Operational Overheads with Every Subspecialty Operating
4.3 Opportunities
4.3.1 Efforts Towards Advanced and Upgraded Pathology Equipment
4.3.2 Strategic Partnership and Agreement among Companies
4.4 Challenges
4.4.1 Lack of Skilled Professionals
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Anatomic Pathology Market, By Services
6.1 Introduction
6.2 Cytopathology
6.3 Histopathology
7 Global Anatomic Pathology Market, By Product
7.1 Introduction
7.2 Consumables
7.2.1 Antibodies
7.2.2 Kits & Reagents
7.2.3 Probes
7.3 Instruments
7.3.1 Cell Processors
7.3.2 Coverslippers
7.3.3 Embedding Systems
7.3.4 Microtomes
7.3.5 Slide Staining Systems
7.3.6 Tissue Processing Systems
8 Global Anatomic Pathology Market, By Application
8.1 Introduction
8.2 Disease Diagnostics
8.3 Medical Research
9 Global Anatomic Pathology Market, By End User
9.1 Introduction
9.2 Clinical Laboratories
9.3 Hospital Laboratories
10 Americas’ Anatomic Pathology Market
10.1 Introduction
10.2 Argentina
10.3 Brazil
10.4 Canada
10.5 Chile
10.6 Colombia
10.7 Mexico
10.8 Peru
10.9 United States
10.10 Rest of Americas
11 Europe’s Anatomic Pathology Market
11.1 Introduction
11.2 Austria
11.3 Belgium
11.4 Denmark
11.5 Finland
11.6 France
11.7 Germany
11.8 Italy
11.9 Netherlands
11.10 Norway
11.11 Poland
11.12 Russia
11.13 Spain
11.14 Sweden
11.15 Switzerland
11.16 United Kingdom
11.17 Rest of Europe
12 Middle East and Africa’s Anatomic Pathology Market
12.1 Introduction
12.2 Egypt
12.3 Israel
12.4 Qatar
12.5 Saudi Arabia
12.6 South Africa
12.7 United Arab Emirates
12.8 Rest of MEA
13 APAC’s Anatomic Pathology Market
13.1 Introduction
13.2 Australia
13.3 Bangladesh
13.4 China
13.5 India
13.6 Indonesia
13.7 Japan
13.8 Malaysia
13.9 Philippines
13.10 Singapore
13.11 South Korea
13.12 Sri Lanka
13.13 Thailand
13.14 Taiwan
13.15 Rest of Asia-Pacific
14 Competitive Landscape
14.1 IGR Competitive Quadrant
14.2 Market Share Analysis
14.3 Strategic Initiatives
14.3.1 M&A and Investments
14.3.2 Partnerships and Collaborations
14.3.3 Product Developments and Improvements
15 Company Profiles
15.1 Agilent Technologies, Inc.
15.2 Associated Regional and University Pathologists, Inc.
15.3 Becton, Dickinson, and Co.
15.4 Bio SB Inc.
15.5 BioGenex Laboratories
15.6 Cardinal Health, Inc.
15.7 Danaher Corp.
15.8 Diapath S.p.A.
15.9 Enzo Biochem, Inc.
15.10 F. Hoffmann-La Roche Ag
15.11 Histo-Line Laboratories
15.12 Hologic, Inc.
15.13 Jinhua Yidi Medical Appliance Co., Ltd.
15.14 Merck KGaA
15.15 NeoGenomics Laboratories, Inc.
15.16 PHC Holdings Corp.
15.17 Quest Diagnostics Inc.
15.18 RareCyte, Inc.
15.19 Sakura Finetek USA, Inc.
15.20 VolitionRx Ltd.
16 Appendix
16.1 Questionnaire
